A Guideline Development Group (GDG) is being assembled by the World Health Organization (WHO) to create evidence-based guidelines for human T-cell lymphotropic virus-1 (HTLV-1)
The Association of Indian Medical Device Industry (AiMeD) has indeed welcomed the initiative taken by the Indian Government to speed up GST refunds for exporters and manufacturers
Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries, announced that the U.S. Food and Drug Administration have approved UZEDY (risperidone). It is an extended-release injection to be administered once-monthly, for...
Turbine, a prominent company focused on the virtualization of biological experiments using AI, has announced a partnership with AstraZeneca to evaluate the capability of Turbine’s platform in rationalizing the discovery of antibody-drug conjugates
Jubilant Pharmova declared that its wholly owned subsidiary, Jubilant HollisterStier LLC (JHS), a major contract manufacturer specializing in sterile injectables in the North American pharmaceutical industry
Integris Medtech is the second-biggest medical technology platform in India that is diversified. It has submitted the Draft Red Herring Prospectus (DRHP) to the Securities and Exchange Board of India
Tamil Nadu is under the spotlight after a spate of child deaths linked to adulterated cough syrup manufactured by Sresan Pharmaceuticals. The deaths have now increased to 23, as two more children, Garvik Pawar, and Mayank Suryawanshi
Thermo Fisher Scientific, has come up with a new lab test which needs to be developed locally, aimed at the better detection of lung transplant rejection and injury. The Molecular Microscope Diagnostic System for Lung
Bayer and Kumquat Biosciences, a clinical-stage biotech company established by pioneers in targeting the KRAS pathway, have announced the start of a Phase I clinical trial for KQB548, an investigational inhibitor aimed at treating KRAS G12D-mutated
Delhi High Court allows Natco Pharma to launch its generic version of Risdiplam for spinal muscular atrophy, offering it at nearly 90% lower price than Roche’s Evrysdi, marking a major win for affordable healthcare access...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")